Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novabay Pharmaceuticals | NBY | Jan 10, 2025 | 0.70 | +9.16 |
Novagold Resources | NG | Jan 10, 2025 | 3.47 | +2.97 |
Novanta | NOVT | Jan 10, 2025 | 147.48 | -2.80 |
Novartis ADR | NVS | Jan 10, 2025 | 99.08 | -1.14 |
Novavax | NVAX | Jan 10, 2025 | 9.31 | -3.02 |
Novo Nordisk ADR | NVO | Jan 10, 2025 | 86.26 | +0.72 |
NovoCure | NVCR | Jan 10, 2025 | 27.45 | -5.05 |
Novonix ADR | NVX | Jan 10, 2025 | 1.86 | -4.12 |
NPK International | NPKI | Jan 10, 2025 | 7.24 | 0.00 |
NRG Energy | NRG | Jan 10, 2025 | 99.39 | +0.86 |
NRx Pharmaceuticals | NRXP | Jan 10, 2025 | 4.85 | +28.99 |
NSTS Bancorp | NSTS | Jan 10, 2025 | 11.31 | -1.70 |
Nu Holdings | NU | Jan 10, 2025 | 10.95 | -1.71 |
Nu Skin Enterprises | NUS | Jan 10, 2025 | 6.22 | -6.47 |
Nuburu | BURU | Jan 10, 2025 | 0.51 | -8.86 |
NuCana ADR | NCNA | Jan 10, 2025 | 1.13 | -1.74 |
Nucor | NUE | Jan 10, 2025 | 118.16 | -0.02 |
Nukkleus | NUKK | Jan 10, 2025 | 18.84 | -10.29 |
Nurix Therapeutics | NRIX | Jan 10, 2025 | 18.24 | -6.51 |
NuScale Power | SMR | Jan 10, 2025 | 20.13 | +2.29 |
Nustar Energy C Pref | NS-C | Jan 10, 2025 | 24.99 | 0.00 |
Nutanix A | NTNX | Jan 10, 2025 | 62.23 | -0.29 |
Nutex Health | NUTX | Jan 10, 2025 | 30.88 | -2.56 |
Nutriband | NTRB | Jan 10, 2025 | 4.13 | -3.28 |
Nutrien | NTR | Jan 10, 2025 | 48.47 | +1.34 |
Nuvalent A | NUVL | Jan 10, 2025 | 76.61 | -2.10 |
Nuvation Bio A | NUVB | Jan 10, 2025 | 2.78 | -7.64 |
Nuvectis Pharma | NVCT | Jan 10, 2025 | 5.81 | -5.83 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Jan 10, 2025 | 12.25 | -0.65 |
Nuveen Amtfree Municipal Value Fund | NUW | Jan 10, 2025 | 13.65 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.